High-Quality Oxaliplatin API Powder: Effective Anti-Cancer Treatment Solution
Advanced platinum-based compound for potent anti-cancer therapy.
Get a Quote & SampleProduct Core Value
Oxaliplatin API Powder
This high-purity Oxaliplatin API powder is a critical component in advanced cancer treatment. It's a third-generation platinum-based antitumor compound renowned for its efficacy in treating metastatic colorectal cancer, particularly in patients who have failed other treatments. Its mechanism involves inhibiting DNA synthesis and replication by forming DNA crosslinks, making it a vital weapon against cancer proliferation.
- Discover the efficacy of Oxaliplatin API powder in combating metastatic colorectal cancer.
- Learn how this platinum-based antitumor compound inhibits DNA synthesis for effective cancer therapy.
- Explore the benefits of using high purity Oxaliplatin for advanced cancer treatments.
- Understand the mechanism of action for Oxaliplatin in treating ovarian cancer and melanoma cell lines.
Advantages Offered by the Product
Potent Anti-Cancer Activity
Exhibit significant activity against colorectal cancer, even in cases resistant to other platinum drugs and 5-FU, highlighting its value in complex treatment regimens.
Advanced Mechanism of Action
By inhibiting DNA synthesis and replication through DNA crosslinks, this compound offers a powerful strategy to combat tumor growth and proliferation.
High Purity and Quality Assurance
The product is supplied as a white powder with a purity exceeding 99%, ensuring reliable and consistent therapeutic outcomes backed by certifications like GMP, ISO, USP, and BP.
Key Applications
Colorectal Cancer Treatment
A cornerstone in the treatment of metastatic colorectal cancer, offering a vital therapeutic option when other treatments have failed.
Ovarian Cancer Therapy
Demonstrates activity against ovarian cancer cell lines, contributing to broader applications in gynecological oncology.
Melanoma Treatment Support
Shows efficacy in inhibiting melanoma cell lines, providing potential benefits in dermatological oncology.
Cancer Research and Development
Serves as a critical pharmaceutical intermediate and API for ongoing research into new anti-cancer therapies and drug combinations.